Jane Street Group LLC Acquires New Position in Dyadic International, Inc. (NASDAQ:DYAI)

Jane Street Group LLC acquired a new stake in shares of Dyadic International, Inc. (NASDAQ:DYAIFree Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 25,711 shares of the biotechnology company’s stock, valued at approximately $45,000. Jane Street Group LLC owned 0.09% of Dyadic International as of its most recent filing with the Securities & Exchange Commission.

Separately, Two Sigma Securities LLC purchased a new position in shares of Dyadic International during the fourth quarter valued at approximately $25,000. Institutional investors own 27.95% of the company’s stock.

Dyadic International Stock Performance

Shares of DYAI opened at $0.98 on Tuesday. The company has a debt-to-equity ratio of 1.54, a quick ratio of 5.15 and a current ratio of 5.15. The company has a market capitalization of $29.56 million, a price-to-earnings ratio of -4.27 and a beta of 0.92. The company’s 50 day simple moving average is $1.13 and its 200 day simple moving average is $1.42. Dyadic International, Inc. has a 1 year low of $0.93 and a 1 year high of $2.27.

Dyadic International (NASDAQ:DYAIGet Free Report) last posted its quarterly earnings results on Wednesday, May 14th. The biotechnology company reported ($0.07) earnings per share for the quarter. The company had revenue of $0.39 million for the quarter. Dyadic International had a negative return on equity of 149.16% and a negative net margin of 188.09%. On average, sell-side analysts predict that Dyadic International, Inc. will post -0.18 EPS for the current year.

Dyadic International Profile

(Free Report)

Dyadic International, Inc, a biotechnology platform company, develops, produces, and sells enzymes and other proteins in the United States and internationally. It utilizes C1-cell protein production platform based on an industrially proven microorganism (C1) for the development and production of biologic products including enzymes and other proteins for human and animal health.

Read More

Institutional Ownership by Quarter for Dyadic International (NASDAQ:DYAI)

Receive News & Ratings for Dyadic International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dyadic International and related companies with MarketBeat.com's FREE daily email newsletter.